IDXX

IDXX

Idexx Laboratories

Medtech / Consumables

★ Quality 96/100
Overvalued

Price today

$535.38

This company value is already calculated

We know what it is worth from its audited numbers, and whether it trades above or below that today. Create your free account to see it.

See what it is worth

charlieapp.co

🏆

A monopoly position

This company has a competitive advantage so strong that its rivals find it practically impossible to replicate.

What this business is made of

96qualityReturnsMoatBalance sheetPricing power *Reinvestment
* That figure exists but does not describe this company, so the axis is left out of the score.

The business

Give away the vet razor, sell the blades forever.

Idexx sells veterinary diagnostics. It places analyzers in clinics and charges for life on the consumables and tests from its reference lab network. Classic razor-and-blade: $4.3B in revenue, most of it recurring.

The installed base of analyzers runs on proprietary consumables — once inside the clinic, switching hurts. Its lab network and management software tie the vet to the whole ecosystem. Replicating that takes decades and thousands of machines already in place.

Revenue history

$3.4B
2022
$3.7B
2023
$3.9B
2024
$4.3B
2025
$4.6B
2026
CAGR 5 años: +8%

From $3.4B to $4.6B in 4 years. The business grows steadily.

Where each $100 of sales goes

Revenue $4.3B · FY2025

Cost of sales$1.6B · 38%
Operations$1.3B · 30%
Taxes and other$301M · 7%
Net profit$1.1B · 25%

Of every $100 in sales, $75 goes to costs and operations; $25 is left as net profit (25% margin).

Catalysts and risks

IDEXX Cancer Dx, launched in 2025, opens a new testing category on top of the existing installed base.

The inVue Dx analyzer expands the diagnostic menu and sells more consumables per clinic.

International expansion, with analyzer penetration still low outside the U.S.

⚠️

U.S. clinic visits have been soft for several quarters; no pet traffic, consumables stall.

⚠️

Mars (Antech) and Zoetis are pushing hard in diagnostics and have deep pockets.

⚠️

At 29x FCF, the price already prices in years of perfect execution. Little room for error.

Charlie's note

Beautiful business: it gets paid every time a dog gets sick and nobody haggles over the vet bill. The problem isn't the quality, it's what you pay for it today.

Analysis · June 2026

Want to follow Idexx Laboratories?

We do not calculate a value here: Idexx Laboratories does not generate cash flows you can project, and putting a number on it would be making it up. What you can do is follow it and tell us the price you care about — we will email you when it gets there.

🔔 Email me

Free · no card

Charlie informs, it doesn't advise. No information should be taken as a recommendation to buy or sell.